Table 2 Functions carried out by the ASPN Therapeutics Development Committee

From: Enhancing clinical trial development for pediatric kidney diseases

Activity Participants
Identifying therapeutic needs All
Evaluating treatments Industry, academic
Identifying scientific needs Academic, NIDDK, NICHD
Ensuring that patient perspective is included Foundations, PCORI
Identifying PI partners and patient populations Academic, industry
Assuring adequacy of studies Industry, academic, FDA
Enhancing collaborative relationships among stakeholders All
  1. ASPN, American Society of Pediatric Nephrology.